Do analysts prefer CER or PRSM?

Cerillion currently has a consensus price target of GBX 1,934, suggesting a potential upside of 84.19%. Given Cerillion's stronger consensus rating and higher possible upside, research analysts clearly believe Cerillion is more favorable than Blue Prism Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerillion 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Blue Prism Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer KAPE or CER?

Cerillion has a consensus price target of GBX 1,934, suggesting a potential upside of 84.19%. Given Cerillion's stronger consensus rating and higher possible upside, analysts plainly believe Cerillion is more favorable than Kape Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kape Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cerillion 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80

Which has preferable valuation and earnings, KAPE or CER?

Kape Technologies has higher revenue and earnings than Cerillion. Kape Technologies is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kape Technologies £623.48M 0.00 £70.92M £0.15 N/A Cerillion £42.46M 7.31 £14.14M £46.30 22.68

Which has higher valuation & earnings, CER or TRST?

Trustpilot Group has higher revenue and earnings than Cerillion. Cerillion is trading at a lower price-to-earnings ratio than Trustpilot Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cerillion £42.46M 7.31 £14.14M £46.30 22.68 Trustpilot Group £261.05M 3.91 £20.08M £1.80 146.67

Do analysts recommend FBT or CER?

Cerillion has a consensus price target of GBX 1,934, suggesting a potential upside of 84.19%. Given Cerillion's stronger consensus rating and higher probable upside, analysts clearly believe Cerillion is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cerillion 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80

Which has stronger earnings & valuation, KNOS or CER?

Kainos Group has higher revenue and earnings than Cerillion. Kainos Group is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kainos Group £431.10M 2.02 £48.81M £35.10 21.50 Cerillion £42.46M 7.31 £14.14M £46.30 22.68

Is KNOS or CER more profitable?

Cerillion has a net margin of 32.24% compared to Kainos Group's net margin of 9.86%. Kainos Group's return on equity of 41.45% beat Cerillion's return on equity. Company Net Margins Return on Equity Return on Assets Kainos Group 9.86% 41.45% 14.45% Cerillion 32.24% 22.77% 19.33%

Cerillion (CER) Competitors

GBX 1,050 0.00 (0.00%)

As of 08:30 AM Eastern

Compare

CER vs. PRSM, KAPE, TRST, FBT, and KNOS

Should you buy Cerillion stock or one of its competitors? MarketBeat compares Cerillion with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cerillion include Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT), and Kainos Group (KNOS). These companies are all part of the "software - application" industry.

How does Cerillion compare to Blue Prism Group?

Cerillion (LON:CER) and Blue Prism Group (LON:PRSM) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

Cerillion has a net margin of 32.24% compared to Blue Prism Group's net margin of 0.00%. Cerillion's return on equity of 22.77% beat Blue Prism Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cerillion	32.24%	22.77%	19.33%
Blue Prism Group	N/A	N/A	N/A

18.5% of Cerillion shares are held by institutional investors. 21.2% of Cerillion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cerillion currently has a consensus price target of GBX 1,934, suggesting a potential upside of 84.19%. Given Cerillion's stronger consensus rating and higher possible upside, research analysts clearly believe Cerillion is more favorable than Blue Prism Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cerillion	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Blue Prism Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Cerillion's average media sentiment score of 1.60 beat Blue Prism Group's score of 0.00 indicating that Cerillion is being referred to more favorably in the media.

Company	Overall Sentiment
Cerillion	Very Positive
Blue Prism Group	Neutral

Cerillion has higher earnings, but lower revenue than Blue Prism Group. Blue Prism Group is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cerillion	£42.46M	7.31	£14.14M	£46.30	22.68
Blue Prism Group	£167.30M	0.00	N/A	-£53.80	N/A

Summary

Cerillion beats Blue Prism Group on 11 of the 12 factors compared between the two stocks.

How does Cerillion compare to Kape Technologies?

Kape Technologies (LON:KAPE) and Cerillion (LON:CER) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

In the previous week, Cerillion's average media sentiment score of 1.60 beat Kape Technologies' score of 0.00 indicating that Cerillion is being referred to more favorably in the news media.

Company	Overall Sentiment
Kape Technologies	Neutral
Cerillion	Very Positive

Kape Technologies has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Cerillion has a beta of 0.497, indicating that its share price is 50% less volatile than the broader market.

11.4% of Kape Technologies shares are owned by institutional investors. Comparatively, 18.5% of Cerillion shares are owned by institutional investors. 81.1% of Kape Technologies shares are owned by company insiders. Comparatively, 21.2% of Cerillion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Cerillion has a consensus price target of GBX 1,934, suggesting a potential upside of 84.19%. Given Cerillion's stronger consensus rating and higher possible upside, analysts plainly believe Cerillion is more favorable than Kape Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kape Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cerillion	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Cerillion has a net margin of 32.24% compared to Kape Technologies' net margin of 11.37%. Cerillion's return on equity of 22.77% beat Kape Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kape Technologies	11.37%	6.97%	3.47%
Cerillion	32.24%	22.77%	19.33%

Kape Technologies has higher revenue and earnings than Cerillion. Kape Technologies is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kape Technologies	£623.48M	0.00	£70.92M	£0.15	N/A
Cerillion	£42.46M	7.31	£14.14M	£46.30	22.68

Summary

Cerillion beats Kape Technologies on 9 of the 14 factors compared between the two stocks.

How does Cerillion compare to Trustpilot Group?

Cerillion (LON:CER) and Trustpilot Group (LON:TRST) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

Cerillion has a beta of 0.497, meaning that its share price is 50% less volatile than the broader market. Comparatively, Trustpilot Group has a beta of 0.507, meaning that its share price is 49% less volatile than the broader market.

Trustpilot Group has higher revenue and earnings than Cerillion. Cerillion is trading at a lower price-to-earnings ratio than Trustpilot Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cerillion	£42.46M	7.31	£14.14M	£46.30	22.68
Trustpilot Group	£261.05M	3.91	£20.08M	£1.80	146.67

In the previous week, Trustpilot Group had 3 more articles in the media than Cerillion. MarketBeat recorded 3 mentions for Trustpilot Group and 0 mentions for Cerillion. Cerillion's average media sentiment score of 1.60 beat Trustpilot Group's score of 0.69 indicating that Cerillion is being referred to more favorably in the media.

Company	Overall Sentiment
Cerillion	Very Positive
Trustpilot Group	Positive

Cerillion currently has a consensus price target of GBX 1,934, indicating a potential upside of 84.19%. Trustpilot Group has a consensus price target of GBX 351.25, indicating a potential upside of 33.05%. Given Cerillion's higher probable upside, analysts plainly believe Cerillion is more favorable than Trustpilot Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cerillion	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Trustpilot Group	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

18.5% of Cerillion shares are held by institutional investors. Comparatively, 42.7% of Trustpilot Group shares are held by institutional investors. 21.2% of Cerillion shares are held by company insiders. Comparatively, 13.5% of Trustpilot Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cerillion has a net margin of 32.24% compared to Trustpilot Group's net margin of 2.97%. Trustpilot Group's return on equity of 64.11% beat Cerillion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cerillion	32.24%	22.77%	19.33%
Trustpilot Group	2.97%	64.11%	1.45%

Summary

Trustpilot Group beats Cerillion on 8 of the 15 factors compared between the two stocks.

How does Cerillion compare to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and Cerillion (LON:CER) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Cerillion has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation	N/A	N/A	N/A	-£1.10	N/A
Cerillion	£42.46M	7.31	£14.14M	£46.30	22.68

In the previous week, Cerillion's average media sentiment score of 1.60 beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's score of 0.00 indicating that Cerillion is being referred to more favorably in the news media.

Company	Overall Sentiment
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation	Neutral
Cerillion	Very Positive

Cerillion has a consensus price target of GBX 1,934, suggesting a potential upside of 84.19%. Given Cerillion's stronger consensus rating and higher probable upside, analysts clearly believe Cerillion is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cerillion	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation has a beta of 0.4890005, meaning that its share price is 51% less volatile than the broader market. Comparatively, Cerillion has a beta of 0.497, meaning that its share price is 50% less volatile than the broader market.

Cerillion has a net margin of 32.24% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. Cerillion's return on equity of 22.77% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation	N/A	N/A	N/A
Cerillion	32.24%	22.77%	19.33%

Summary

Cerillion beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 13 of the 13 factors compared between the two stocks.

How does Cerillion compare to Kainos Group?

Kainos Group (LON:KNOS) and Cerillion (LON:CER) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

Kainos Group pays an annual dividend of GBX 28.90 per share and has a dividend yield of 3.8%. Cerillion pays an annual dividend of GBX 15.40 per share and has a dividend yield of 1.5%. Kainos Group pays out 82.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cerillion pays out 33.3% of its earnings in the form of a dividend.

In the previous week, Kainos Group had 3 more articles in the media than Cerillion. MarketBeat recorded 3 mentions for Kainos Group and 0 mentions for Cerillion. Cerillion's average media sentiment score of 1.60 beat Kainos Group's score of 0.60 indicating that Cerillion is being referred to more favorably in the news media.

Company	Overall Sentiment
Kainos Group	Positive
Cerillion	Very Positive

Kainos Group currently has a consensus target price of GBX 1,173.40, indicating a potential upside of 55.52%. Cerillion has a consensus target price of GBX 1,934, indicating a potential upside of 84.19%. Given Cerillion's higher possible upside, analysts plainly believe Cerillion is more favorable than Kainos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kainos Group	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cerillion	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

36.8% of Kainos Group shares are owned by institutional investors. Comparatively, 18.5% of Cerillion shares are owned by institutional investors. 19.7% of Kainos Group shares are owned by company insiders. Comparatively, 21.2% of Cerillion shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Kainos Group has higher revenue and earnings than Cerillion. Kainos Group is trading at a lower price-to-earnings ratio than Cerillion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kainos Group	£431.10M	2.02	£48.81M	£35.10	21.50
Cerillion	£42.46M	7.31	£14.14M	£46.30	22.68

Kainos Group has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Cerillion has a beta of 0.497, meaning that its share price is 50% less volatile than the broader market.

Cerillion has a net margin of 32.24% compared to Kainos Group's net margin of 9.86%. Kainos Group's return on equity of 41.45% beat Cerillion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kainos Group	9.86%	41.45%	14.45%
Cerillion	32.24%	22.77%	19.33%

Summary

Kainos Group and Cerillion tied by winning 9 of the 18 factors compared between the two stocks.

Get Cerillion News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CER vs. The Competition

Export

Metric	Cerillion	Software Industry	Computer Sector	LON Exchange
Market Cap	£310.18M	£5.08B	£39.02B	£2.78B
Dividend Yield	1.50%	4.07%	3.18%	6.15%
P/E Ratio	22.68	26.47	77.86	369.58
Price / Sales	7.31	240.34	601.92	84,558.28
Price / Cash	17.49	17.56	46.23	27.87
Price / Book	6.39	4.28	9.54	7.64
Net Income	£14.14M	£22.26M	£1.07B	£5.89B
7 Day Performance	-1.87%	-0.17%	-1.95%	-0.63%
1 Month Performance	-14.98%	-0.99%	-1.18%	-1.15%
1 Year Performance	-31.46%	-13.92%	138.94%	61.83%

Cerillion Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CER Cerillion	3.9953 of 5 stars	GBX 1,050 flat	GBX 1,934 +84.2%	-31.5%	£310.18M	£42.46M	22.68	321	Positive News
PRSM Blue Prism Group	N/A	N/A	N/A	N/A	£1.24B	£167.30M	N/A	1,025	High Trading Volume
KAPE Kape Technologies	N/A	N/A	N/A	N/A	£1.22B	£623.48M	1,900.00	850	Gap Down
TRST Trustpilot Group	3.9255 of 5 stars	GBX 233.47 -1.1%	GBX 351.25 +50.4%	+15.4%	£902.88M	£261.05M	129.70	820
FBT First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation	N/A	GBX 2,200 -0.5%	N/A	+60.5%	£902.47M	N/A	N/A	20	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:CER) was last updated on 7/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cerillion (CER) Competitors

CER vs. PRSM, KAPE, TRST, FBT, and KNOS

How does Cerillion compare to Blue Prism Group?

Summary

How does Cerillion compare to Kape Technologies?

Summary

How does Cerillion compare to Trustpilot Group?

Summary

How does Cerillion compare to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation?

Summary

How does Cerillion compare to Kainos Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CER vs. The Competition

Cerillion Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cerillion (CER) Competitors

CER vs. PRSM, KAPE, TRST, FBT, and KNOS

How does Cerillion compare to Blue Prism Group?

Is CER or PRSM more profitable?

Do insiders and institutionals believe in CER or PRSM?

Do analysts prefer CER or PRSM?

Does the media prefer CER or PRSM?

Which has preferable valuation and earnings, CER or PRSM?

Summary

How does Cerillion compare to Kape Technologies?

Does the media prefer KAPE or CER?

Which has more volatility & risk, KAPE or CER?

Do insiders & institutionals hold more shares of KAPE or CER?

Do analysts prefer KAPE or CER?

Is KAPE or CER more profitable?

Which has preferable valuation and earnings, KAPE or CER?

Summary

How does Cerillion compare to Trustpilot Group?

Which has more risk and volatility, CER or TRST?

Which has higher valuation & earnings, CER or TRST?

Does the media favor CER or TRST?

Do analysts prefer CER or TRST?

Do institutionals and insiders believe in CER or TRST?

Is CER or TRST more profitable?

Summary

How does Cerillion compare to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation?

Which has stronger valuation and earnings, FBT or CER?

Does the media refer more to FBT or CER?

Do institutionals & insiders hold more shares of FBT or CER?

Do analysts recommend FBT or CER?

Which has more risk and volatility, FBT or CER?

Is FBT or CER more profitable?

Summary

How does Cerillion compare to Kainos Group?

Is KNOS or CER a better dividend stock?

Does the media refer more to KNOS or CER?

Do analysts prefer KNOS or CER?

Do insiders and institutionals believe in KNOS or CER?

Which has stronger earnings & valuation, KNOS or CER?

Which has more risk and volatility, KNOS or CER?

Is KNOS or CER more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CER vs. The Competition

Cerillion Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools